Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

KALA BIO

Explore full profile

Development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles

Waltham, United StatesFounded 2009Biotech & Life Sciences
Valuation $3.7M Market cap · 2026

About KALA BIO

KALA BIO is a clinical-stage biopharmaceutical company that researches, develops, and commercializes therapies for rare and severe eye diseases.

The company is advancing the clinical development of KPI-012 for the treatment of Persistent Corneal Epithelial Defect (PCED), a rare disease of the cornea that can lead to vision loss. KALA BIO has hosted a Key Opinion Leader (KOL) event to discuss the potential of KPI-012 for the treatment of PCED.

To fund its operations and the clinical development of its product candidates, the company raises capital through private placements. For instance, KALA BIO has recently announced a private placement to advance the clinical development of KPI-012.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2009
Headquarters
Waltham, United States
Listing
IPO 2017
Sector
Biotech & Life Sciences

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

Series B and later7 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 24 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom4.2%
🇨🇦 Canada4.2%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about KALA BIO on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See KALA BIO on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles